These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18187184)

  • 21. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma.
    Honkavuori M; Talvensaari-Mattila A; Soini Y; Turpeenniemi-Hujanen T; Santala M
    Gynecol Oncol; 2007 Jan; 104(1):217-21. PubMed ID: 16996112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.
    Dai DL; Makretsov N; Campos EI; Huang C; Zhou Y; Huntsman D; Martinka M; Li G
    Clin Cancer Res; 2003 Oct; 9(12):4409-14. PubMed ID: 14555513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
    Talvensaari-Mattila A; Santala M; Soini Y; Turpeenniemi-Hujanen T
    Anticancer Res; 2005; 25(6B):4101-5. PubMed ID: 16309203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.
    Aglund K; Rauvala M; Puistola U; Angström T; Turpeenniemi-Hujanen T; Zackrisson B; Stendahl U
    Gynecol Oncol; 2004 Sep; 94(3):699-704. PubMed ID: 15350361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
    Luukkaa H; Klemi P; Hirsimäki P; Vahlberg T; Kivisaari A; Kähäri VM; Grénman R
    Acta Otolaryngol; 2008 Apr; 128(4):482-90. PubMed ID: 18368586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients.
    Campos RS; Lopes A; Guimarães GC; Carvalho AL; Soares FA
    Urology; 2006 Apr; 67(4):797-802. PubMed ID: 16566971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
    Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S
    Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
    Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
    Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
    Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ING4 in human melanoma cell migration, invasion and patient survival.
    Li J; Martinka M; Li G
    Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
    Chen Y; Chen Y; Huang L; Yu J
    J Dermatol; 2012 Apr; 39(4):339-43. PubMed ID: 22150440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
    Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
    Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of oncogene expression as an independent prognostic marker for primary melanoma.
    Grover R; Pacifico MD; Wilson GD; Sanders R
    Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.